Literature DB >> 32364561

Randomized Clinical Trials and COVID-19: Managing Expectations.

Howard Bauchner1, Phil B Fontanarosa2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32364561     DOI： 10.1001/jama.2020.8115

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  34 in total

1.  An ethics framework for consolidating and prioritizing COVID-19 clinical trials.

Authors:  Michelle N Meyer; Luke Gelinas; Barbara E Bierer; Sara Chandros Hull; Steven Joffe; David Magnus; Seema Mohapatra; Richard R Sharp; Kayte Spector-Bagdady; Jeremy Sugarman; Benjamin S Wilfond; Holly Fernandez Lynch
Journal:  Clin Trials       Date:  2021-02-02       Impact factor: 2.486

2.  An ordinal severity scale for COVID-19 retrospective studies using Electronic Health Record data.

Authors:  Maryam Khodaverdi; Bradley S Price; J Zachary Porterfield; H Timothy Bunnell; Michael T Vest; Alfred Jerrod Anzalone; Jeremy Harper; Wes D Kimble; Hamidreza Moradi; Brian Hendricks; Susan L Santangelo; Sally L Hodder
Journal:  JAMIA Open       Date:  2022-07-09

3.  Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.

Authors:  Haitham M H Qutob; Ramadan A Saad; Hamza Bali; Abdulaziz Osailan; Jumana Jaber; Emad Alzahrani; Jamilah Alyami; Hani Elsayed; Raed Alserihi; Osama A Shaikhomar
Journal:  Med Clin (Barc)       Date:  2022-04-25       Impact factor: 3.200

Review 4.  COVID-19: From pathogenesis models to the first drug trials.

Authors:  Harald Brüssow
Journal:  Microb Biotechnol       Date:  2020-06-23       Impact factor: 5.813

5.  Deficiencies in the Designs and Interventions of COVID-19 Clinical Trials.

Authors:  David Hsiehchen; Magdalena Espinoza; Antony Hsieh
Journal:  Med (N Y)       Date:  2020-07-04

Review 6.  International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection.

Authors:  Michael Murphy; Lise Estcourt; John Grant-Casey; Sunny Dzik
Journal:  Transfus Med Rev       Date:  2020-06-27

7.  Aggregating data from COVID-19 trials.

Authors:  Elizabeth L Ogburn; Barbara E Bierer; Ron Brookmeyer; Christine Choirat; Natalie E Dean; Victor De Gruttola; Susan S Ellenberg; M Elizabeth Halloran; Daniel F Hanley; Joseph K Lee; Rui Wang; Daniel O Scharfstein
Journal:  Science       Date:  2020-06-12       Impact factor: 47.728

8.  Sleep quality and associated factors during the COVID-19 epidemic among community non-medical anti-epidemic Workers of Wuhan, China.

Authors:  Guanglin Si; Yi Xu; Mengying Li; Yuting Zhang; Shuzhen Peng; Xiaodong Tan
Journal:  BMC Public Health       Date:  2021-06-30       Impact factor: 3.295

Review 9.  Erythropoietin as candidate for supportive treatment of severe COVID-19.

Authors:  Hannelore Ehrenreich; Karin Weissenborn; Martin Begemann; Markus Busch; Eduard Vieta; Kamilla W Miskowiak
Journal:  Mol Med       Date:  2020-06-16       Impact factor: 6.354

10.  Waste in COVID-19 clinical trials conducted in western Europe.

Authors:  Rafael Dal-Ré; Ignacio Mahillo-Fernández
Journal:  Eur J Intern Med       Date:  2020-07-07       Impact factor: 4.487
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.